SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-046455
Filing Date
2023-06-06
Accepted
2023-06-06 06:05:49
Documents
4
Period of Report
2023-06-20

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a0623_allaritythera.htm DEF 14A 461461
2 GRAPHIC tallarity_logo.jpg GRAPHIC 60668
3 GRAPHIC tproxy_001.jpg GRAPHIC 1589751
4 GRAPHIC tproxy_002.jpg GRAPHIC 1290126
  Complete submission text file 0001213900-23-046455.txt   4513115
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41160 | Film No.: 23994796
SIC: 2834 Pharmaceutical Preparations